Showing results (121-130 of 191) with videos related to

Sort By:
Pageof 20
Japanese Journal of Clinical Oncology|May 10, 2019
Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202)Akihiko Miyanaga, Kaoru Kubota, Yukio Hosomi, et al.
Anticancer Research|May 27, 2026
The Association Between Longitudinal Changes in TRACP-5b and Bone Metastasis Progression During Osimertinib TherapyKeisuke Ikegami, Reiko Ando Makihara, Yuki Shinno, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|February 27, 2019
Sublingual administration of liposomes enclosing alpha-galactosylceramide as an effective adjuvant of allergen immunotherapy in a murine model of allergic rhinitisSatoshi Suzuki, Daiju Sakurai, Toshioki Sakurai, et al.
Clinical Lung Cancer|February 27, 2024
Artemis: A Multicenter, Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of First-Line Carboplatin/Paclitaxel/Lenvatinib/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic CarcinomasYusuke Okuma, Shogo Nomura, Jun Sakakibara-Konishi, et al.
Japanese Journal of Clinical Oncology|January 3, 2022
Performance of Japanese patients in registrational studiesYasushi Goto, Sayaka Arakawa, Masayuki Shirasawa, et al.
Clinical Lung Cancer|July 30, 2024
Impact of Durvalumab on the Duration and Complexity of Corticosteroid Therapy for Pneumonitis After ChemoradiotherapySaori Murata, Hidehito Horinouchi, Momoko Morishita, et al.
Clinical Lung Cancer|February 15, 2024
Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Non-Small Cell Lung Cancer Patients with Poor Performance Status and Epidermal Growth Factor Receptor Mutations: Findings from the Japanese Lung Cancer Registry DatabaseYusuke Okuma, Yasushi Shintani, Ikuo Sekine, et al.
Cancer Immunology, Immunotherapy : CII|April 16, 2023
Incidence of serious adverse events caused by tyrosine kinase inhibitor treatment following immune checkpoint inhibitor therapy in advanced NSCLC patients with oncogenic driver alterationsYukiko Shimoda, Tatsuya Yoshida, Jun Miyakoshi, et al.
Cancers|November 11, 2022
Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota AnalysisTaiki Hakozaki, Alexis Nolin-Lapalme, Masato Kogawa, et al.
Thoracic Cancer|January 14, 2025
Schlafen 11 Expression in Patients With Small Cell Lung Cancer and Its Association With Clinical OutcomesKen Masuda, Tatsuya Yoshida, Noriko Motoi, et al.
Pageof 20